Kyntra Bio annual gross profit
2019
2020
2021
2022
2023
2024
2025
Kyntra Bio Gross Profit Growth & History (KYNB)
Kyntra Bio's gross profit was $5.9M for fiscal 2025.
View full Kyntra Bio company overviewKyntra Bio annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $5.9M | −$8.2M | −58.15% |
| 2024 | 2024-12-31 | $14.1M | −$28.8M | −67.18% |
| 2023 | 2023-12-31 | $42.8M | −$77.6M | −64.43% |
| 2022 | 2022-12-31 | $120.5M | −$102.0M | −45.85% |
| 2021 | 2021-12-31 | $222.4M | $55.0M | +32.84% |
| 2020 | 2020-12-31 | $167.4M | −$88.0M | −34.44% |
| 2019 | 2019-12-31 | $255.4M | — | — |
Kyntra Bio quarterly gross profit
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$1.5M | −$2.7M | — |
| Q1 2026 | 2026-03-31 | −$368,000 | −$2.9M | — |
| Q4 2025 | 2025-12-31 | $999,000 | $32.9M | — |
| Q3 2025 | 2025-09-30 | $1.1M | −$39.9M | −97.24% |
| Q2 2025 | 2025-06-30 | $1.3M | $405,000 | +47.20% |
| Q1 2025 | 2025-03-31 | $2.5M | −$1.5M | −38.15% |
| Q4 2024 | 2024-12-31 | −$31.9M | $32.5M | — |
| Q3 2024 | 2024-09-30 | $41.0M | $5.1M | +14.34% |
| Q2 2024 | 2024-06-30 | $858,000 | −$37.8M | −97.78% |
| Q1 2024 | 2024-03-31 | $4.0M | −$28.6M | −87.69% |
| Q4 2023 | 2023-12-31 | −$64.3M | −$93.8M | — |
| Q3 2023 | 2023-09-30 | $35.9M | $24.5M | +214.09% |
| Q2 2023 | 2023-06-30 | $38.6M | $15.6M | +67.90% |
| Q1 2023 | 2023-03-31 | $32.7M | −$23.9M | −42.27% |
| Q4 2022 | 2022-12-31 | $29.4M | $16.0M | +119.43% |
| Q3 2022 | 2022-09-30 | $11.4M | −$141.3M | −92.52% |
| Q2 2022 | 2022-06-30 | $23.0M | $1.7M | +8.04% |
| Q1 2022 | 2022-03-31 | $56.6M | $21.6M | +61.55% |
| Q4 2021 | 2021-12-31 | $13.4M | — | — |
| Q3 2021 | 2021-09-30 | $152.7M | $110.9M | +265.11% |
| Q2 2021 | 2021-06-30 | $21.3M | — | — |
| Q1 2021 | 2021-03-31 | $35.0M | — | — |
| Q3 2020 | 2020-09-30 | $41.8M | — | — |
Kyntra Bio gross profit trends
Over the last five fiscal years, Kyntra Bio's gross profit decreased from $167.4M to $5.9M, a change of −$161.6M. The latest reported quarter, Q2 2026, shows −$1.5M.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Kyntra Bio source filings ↗